Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
ClH/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35
NVP-231 synergistically increased ceramide levels and reduced cell growth
Ginkgolide B (2 μM) significantly inhibits MDCK cyst formation dose dependently
2]octan-3-yl N-(3-fluorophenyl)-N-[(3
51(6):407-12
Ziprasidone - CAS# 146939-27-7 dacaterol maleate ClH/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35Ziprazidone is approved for the treatment of schizophrenia, and acute mania and mixed states associated with bipolar disorder. Its intramuscular injection form is approved for acute agitation in schizophrenic patients for whom treatment with just ziprasidone is appropriate. The mechanism of action of ziprasidone, as with other drugs having efficacy in schizophrenia, is unknown. However, it has been proposed that this drug's efficacy in schizophrenia